Company and Contact Information Sample Clauses

Company and Contact Information. Changes regarding Contractor’s company and/or contact information should be submitted no later than five (5) business days of the change to the OGS Contract Administrator.
Sample 1Sample 2Sample 3See All (12)
Company and Contact Information. It is Your responsibility to keep the information and key contact information We use to communicate with You up to date through the App or Online Account (or other customer portal as advised to you from time to time). This includes but is not limited to email addresses, phone numbers, company address, Tax/VAT, and registration details as locally applicable. Your contact address details must be a legitimate business address or residential address of the primary contact; it must not be an IWG Center address (or other business center address).
Sample 1
Company and Contact Information. Nine23 is a privately held, limited company, registered in England with number: 08118696, and address: 0 Xxxxxxx Xxxx, University of Southampton Science Park, SO16 7NP Nine23 Ltd holds insurance for: Professional Indemnity, Employers Liability, Public & Products Liability, Buildings/Tenants Liability, Contents at premises (Computers), Contents at premises (Other), Contents away from premises, Business Interruption (Loss of Income), Business Interruption (Increased Cost of Working), Legal Expenses for a sum of £2,000,000 each claim except Public & Products Liability which is covered by £5,000,000. Company and Contact Information 3 How We Work 7 Our Model 7 Define - your problem 7 Build - your solution 7 Manage - your service 7 SECTION ONE: OVERVIEW 8 Executive Summary of the service 8 Service summary in detail 9 Service description 9 Service Features 9 Service Benefits 9 Who needs Platform FLEX? 11 How it works 12 Features: 12 Commercials and pricing 13 Service pricing model 13 Hosting options 13 Minimum contract period 13 Termination 14 Financial recompense 14 User interface customisation 14 Service integration 14 Maintenance and lifecycle management 14 Data restoration/Service migration 14 Customer responsibilities 14 SECTION TWO: RATIONALE 15 Why choose Nine23? 15 SECTION THREE: COMPLIANCE 17 Information Assurance 17 Accreditation 18 Cloud Security Principles 18 SECTION FOUR: SERVICE LEVEL MANAGEMENT 19 Role and Responsibilities 19 Measurement of service 19 Service Exclusions 19 Exceptions 19 Service Improvement Plan 20 Roles and Responsibilities 20 Service Desk 20 Service Desk Escalation Process 21 Scope 21 Incident Management 21 Roles and Responsibilities 21 Change Control 22 Problem Management 22 Roles and Responsibilities 22 Protective Monitoring 22 Patch Management 23 Backup/restore 23 Ad-Hoc Requests / Projects 23 APPENDICES 24 Appendix i: Platform FLEX Service Management 24 Service Summary 24 Items outside scope of Support 24 Responsibilities 25 On-boarding process 25 Off-boarding process 26 Service provisioning 26 Service Availability 26 Service Desk Core Service Hours 27 Incident Priority Criteria 28 Service Requests 29 Reporting 29 Appendix ii: Support Services & 30 Training 30 Support service level agreement 30 Scope of service support 30 Service support procedure 30 Support escalation procedure 31 Project Management 31 Development 31 Infrastructure 31 Further information 31 How We Work Our Model Today’s digital environment is increasingly com...
Sample 1
Company and Contact Information. A. COMPANY INFORMATION (REQUIRED) Company Name: DBA: Stock Symbol (if publicly traded organization): Federal Tax ID: Address: City: State: Zip: Type of business location (for example, residential or commercial office space): Telephone: Fax: Company Web Addresses (URLs): IP Address (IPV4): IP Address Range (IPV4): to Type of Business: ● Sole Proprietor ● Corporation ● Partnership/LLC Business Industry: Business Description: (Include the purpose for which the Services will be used)
Sample 1

Related to Company and Contact Information

  • Contact Information 1. The contact information of the Programme Operator is as specified in this programme agreement.

  • Client Information (2) Protected Health Information in any form including without limitation, Electronic Protected Health Information or Unsecured Protected Health Information (herein “PHI”);

  • Trade Secrets and Confidential Information/Company Property Employee reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreement, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and nonsolicitation of Company employees. Employee’s signature below constitutes his/her certification under penalty of perjury that he/she has returned all documents and other items provided to Employee by the Company, developed or obtained by Employee in connection with his/her employment with the Company, or otherwise belonging to the Company.

  • Proprietary and Confidential Information The Distributor agrees on behalf of itself and its managers, officers, and employees to treat confidentially and as proprietary information of the Trust, all records and other information relative to the Trust and prior, present or potential shareholders of the Trust (and clients of said shareholders), and not to use such records and information for any purpose other than the performance of its responsibilities and duties hereunder, except (i) after prior notification to and approval in writing by the Trust, which approval shall not be unreasonably withheld and may not be withheld where the Distributor may be exposed to civil or criminal contempt proceedings for failure to comply, (ii) when requested to divulge such information by duly constituted authorities, or (iii) when so requested by the Trust. Records and other information which have become known to the public through no wrongful act of the Distributor or any of its employees, agents or representatives, and information that was already in the possession of the Distributor prior to receipt thereof from the Trust or its agent, shall not be subject to this paragraph. Further, the Distributor will adhere to the privacy policies adopted by the Trust pursuant to Title V of the Gxxxx-Xxxxx-Xxxxxx Act, as may be modified from time to time. In this regard, the Distributor shall have in place and maintain physical, electronic and procedural safeguards reasonably designed to protect the security, confidentiality and integrity of, and to prevent unauthorized access to or use of, records and information relating to the Trust and its shareholders.

  • Trade Secrets and Confidential Information The Executive represents and warrants that: (i) the Executive is not subject to any legal or contractual duty or agreement that would prevent or prohibit the Executive from performing the Executive’s Duties for the Company or otherwise complying with this Agreement, and (ii) the Executive is not in breach of any legal or contractual duty or agreement, including any agreement concerning trade secrets or confidential information owned by any other party. The Executive agrees that the Executive will not: (1) use, disclose, or reverse engineer the Trade Secrets or the Confidential Information for any purpose other than the Company’s Business, except as authorized in writing by the Company; (2) during the Executive’s employment with the Company, use, disclose, or reverse engineer (a) any confidential information or trade secrets of any former employer or third party, or (b) any works of authorship developed in whole or in part by the Executive during any former employment or for any other party, unless authorized in writing by the former employer or third party; or (3) upon the Executive’s resignation or termination (a) retain Trade Secrets or Confidential Information, including any copies existing in any form (including electronic form), which are in the Executive’s possession or control, or (b) destroy, delete, or alter the Trade Secrets or Confidential Information without the Company’s written consent. The obligations under this subsection A shall: (I) with regard to the Trade Secrets, remain in effect as long as the information constitutes a trade secret under applicable law, and (II) with regard to the Confidential Information, remain in effect during the Restricted Period. The confidentiality, property, and proprietary rights protections available in this Agreement are in addition to, and not exclusive of, any and all other rights to which the Company is entitled under federal and state law, including, but not limited to, rights provided under copyright laws, trade secret and confidential information laws, and laws concerning fiduciary duties.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Contact a. In accordance with section 215.971(2), Florida Statutes, the Division’s Grant Manager shall be responsible for enforcing performance of this Agreement’s terms and conditions and shall serve as the Division’s liaison with the Sub-Recipient. As part of his/her duties, the Grant Manager for the Division shall: payment.

  • Scope of Confidential Information Executive acknowledges that the Company has developed, and will during the term of Executive’s employment continue to develop, substantial, confidential, competitively valuable information and other intangible or “intellectual property” in connection with its business, some or all of which is proprietary to the Company, (collectively, the “Confidential Information”). Without limiting the generality of the preceding sentence, Executive expressly recognizes and agrees that, subject to the remainder of this Section 5.2, the following items, and all copies, summaries, extracts or derivative works thereof, are entitled to trade secret protection and constitute Confidential Information under this Agreement, whether developed prior to the date hereof or thereafter, and whether with the assistance of Executive or otherwise: (i) the Company’s proprietary computer software, databases and lists of customers, prospects, candidates, and employees; employee applications; skills inventory sheets and similar summaries of employee qualifications, as well as employee compensation; customer ordering habits, billing rates, buying preferences, and short term needs; sales reports and analysis; (ii) employee reports and analysis; customer job orders and profit margin data; businesses processes, methods of operation and sales techniques; (iii) statistical information regarding the Company; (iv) financial information of the Company and its customers that is not publicly available; (v) specially negotiated terms and pricing with vendors and customers; (vi) research and development, business projects, strategic business plans, and strategies; products and solution services offered to customers; and (vii) any other non-public information of the Company that gives the Company a competitive advantage by virtue of it not being generally known. Notwithstanding the foregoing, the Confidential Information shall not include (a) any information which is or becomes publicly available, other than as a result of the wrongful action of Executive or his agents; (b) any information independently developed by Executive subsequent to the Date of Termination; (c) any information made available to Executive following the termination of Executive’s employment from a third party not known by Executive to be under binder of confidentiality to the Company with regard thereto or (d) any information as to which the Company specifically waives its rights hereunder pursuant to an instrument in writing.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!